Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Jolly

Showing results (211-220 of 233) with videos related to

Pageof 24
Sort By:
The Oncologist|December 16, 2018
Patient-Reported Toxicities During Chemotherapy Regimens in Current Clinical Practice for Early Breast CancerKirsten A Nyrop, Allison M Deal, Shlomit S Shachar, et al.
Cancer|May 16, 2019
Patient-reported and clinician-reported chemotherapy-induced peripheral neuropathy in patients with early breast cancer: Current clinical practiceKirsten A Nyrop, Allison M Deal, Kathryn E Reeder-Hayes, et al.
Cancer|April 22, 2020
Congruence of patient- and clinician-reported toxicity in women receiving chemotherapy for early breast cancerKirsten A Nyrop, Allison M Deal, Bryce B Reeve, et al.
Human Mutation|June 3, 2021
Integrated in silico and experimental assessment of disease relevance of PCDH19 missense variantsDuyen H Pham, Melissa R Pitman, Raman Kumar, et al.
Human Molecular Genetics|December 16, 2014
Homozygous mutation of STXBP5L explains an autosomal recessive infantile-onset neurodegenerative disorderRaman Kumar, Mark A Corbett, Nicholas J C Smith, et al.
Cancer Medicine|January 16, 2023
A phase II single-arm trial of memantine for prevention of cognitive decline during chemotherapy in patients with early breast cancer: Feasibility, tolerability, acceptability, and preliminary effectsZev M Nakamura, Allison M Deal, Eliza M Park, et al.
Nature Communications|February 8, 2024
Compromised transcription-mRNA export factor THOC2 causes R-loop accumulation, DNA damage and adverse neurodevelopmentRudrarup Bhattacharjee, Lachlan A Jolly, Mark A Corbett, et al.
Medrxiv : the Preprint Server for Health Sciences|March 23, 2026
Novel <i>PCDH12</i> pathogenic missense variants cause neurodevelopmental disorders with ocular malformationJennifer Rakotomamonjy, Lucas Fares-Taie, Raman Kumar, et al.
American Journal of Human Genetics|July 14, 2015
THOC2 Mutations Implicate mRNA-Export Pathway in X-Linked Intellectual DisabilityRaman Kumar, Mark A Corbett, Bregje W M van Bon, et al.
NPJ Genomic Medicine|December 10, 2020
Missense variant contribution to USP9X-female syndromeLachlan A Jolly, Euan Parnell, Alison E Gardner, et al.
Pageof 24

Showing results (211-220 of 233) with videos related to

Sort By:
Pageof 24
The Oncologist|December 16, 2018
Patient-Reported Toxicities During Chemotherapy Regimens in Current Clinical Practice for Early Breast CancerKirsten A Nyrop, Allison M Deal, Shlomit S Shachar, et al.
Cancer|May 16, 2019
Patient-reported and clinician-reported chemotherapy-induced peripheral neuropathy in patients with early breast cancer: Current clinical practiceKirsten A Nyrop, Allison M Deal, Kathryn E Reeder-Hayes, et al.
Cancer|April 22, 2020
Congruence of patient- and clinician-reported toxicity in women receiving chemotherapy for early breast cancerKirsten A Nyrop, Allison M Deal, Bryce B Reeve, et al.
Human Mutation|June 3, 2021
Integrated in silico and experimental assessment of disease relevance of PCDH19 missense variantsDuyen H Pham, Melissa R Pitman, Raman Kumar, et al.
Human Molecular Genetics|December 16, 2014
Homozygous mutation of STXBP5L explains an autosomal recessive infantile-onset neurodegenerative disorderRaman Kumar, Mark A Corbett, Nicholas J C Smith, et al.
Cancer Medicine|January 16, 2023
A phase II single-arm trial of memantine for prevention of cognitive decline during chemotherapy in patients with early breast cancer: Feasibility, tolerability, acceptability, and preliminary effectsZev M Nakamura, Allison M Deal, Eliza M Park, et al.
Nature Communications|February 8, 2024
Compromised transcription-mRNA export factor THOC2 causes R-loop accumulation, DNA damage and adverse neurodevelopmentRudrarup Bhattacharjee, Lachlan A Jolly, Mark A Corbett, et al.
Medrxiv : the Preprint Server for Health Sciences|March 23, 2026
Novel <i>PCDH12</i> pathogenic missense variants cause neurodevelopmental disorders with ocular malformationJennifer Rakotomamonjy, Lucas Fares-Taie, Raman Kumar, et al.
American Journal of Human Genetics|July 14, 2015
THOC2 Mutations Implicate mRNA-Export Pathway in X-Linked Intellectual DisabilityRaman Kumar, Mark A Corbett, Bregje W M van Bon, et al.
NPJ Genomic Medicine|December 10, 2020
Missense variant contribution to USP9X-female syndromeLachlan A Jolly, Euan Parnell, Alison E Gardner, et al.
Pageof 24